¿Qué es la enfermedad de Alzheimer?






descargar 0.56 Mb.
título¿Qué es la enfermedad de Alzheimer?
página9/9
fecha de publicación27.03.2017
tamaño0.56 Mb.
tipoDocumentos
med.se-todo.com > Documentos > Documentos
1   2   3   4   5   6   7   8   9




  1. 1: Manos PJ.Ten-point clock test sensitivity for Alzheimer's disease in patients with MMSE
    scores greater than 23.
    Int J Geriatr Psychiatry. 1999 Jun;14(6):454-8.
    PMID: 10398355 [PubMed - indexed for MEDLINE]



  2. 1: Petrosian AA, Prokhorov DV, Lajara-Nanson W, Schiffer RB.Recurrent neural network-based approach for early recognition of Alzheimer's
    disease in EEG.
    Clin Neurophysiol. 2001 Aug;112(8):1378-87.
    PMID: 11459677 [PubMed - indexed for MEDLINE]




2: Adler G, Brassen S.Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer
patients.
Neuropsychobiology. 2001;43(4):273-6.
PMID: 11340368 [PubMed - indexed for MEDLINE]


3: Jeong J, Gore JC, Peterson BS.Mutual information analysis of the EEG in patients with Alzheimer's disease.
Clin Neurophysiol. 2001 May;112(5):827-35.
PMID: 11336898 [PubMed - indexed for MEDLINE]


4: Knott V, Mohr E, Mahoney C, Ilivitsky V.Quantitative electroencephalography in Alzheimer's disease: comparison with a
control group, population norms and mental status.
J Psychiatry Neurosci. 2001 Mar;26(2):106-16.
PMID: 11291527 [PubMed - indexed for MEDLINE]


5: Jeong J, Chae JH, Kim SY, Han SH.Nonlinear dynamic analysis of the EEG in patients with Alzheimer's disease and
vascular dementia.
J Clin Neurophysiol. 2001 Jan;18(1):58-67.
PMID: 11290940 [PubMed - indexed for MEDLINE]


6: Huang C, Wahlund L, Dierks T, Julin P, Winblad B, Jelic V.Discrimination of Alzheimer's disease and mild cognitive impairment by
equivalent EEG sources: a cross-sectional and longitudinal study.
Clin Neurophysiol. 2000 Nov;111(11):1961-7.
PMID: 11068230 [PubMed - indexed for MEDLINE]


7: Ikawa M, Nakanishi M, Furukawa T, Nakaaki S, Hori S, Yoshida S.Relationship between EEG dimensional complexity and neuropsychological findings
in Alzheimer's disease.
Psychiatry Clin Neurosci. 2000 Oct;54(5):537-41.
PMID: 11043802 [PubMed - indexed for MEDLINE]


8: Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, MaurerK, Winblad B, Nordberg A.
Spatial pattern of cerebral glucose metabolism (PET) correlates with
localization of intracerebral EEG-generators in Alzheimer's disease.
Clin Neurophysiol. 2000 Oct;111(10):1817-24.
PMID: 11018498 [PubMed - indexed for MEDLINE]


9: Adler G.

[The EEG as an indicator of cholinergic deficit in Alzheimer's disease] Fortschr Neurol Psychiatr. 2000 Aug;68(8):352-6. Review. German. PMID: 11006862 [PubMed - indexed for MEDLINE]

10: Dringenberg HC.Alzheimer's disease: more than a 'cholinergic disorder' - evidence that
cholinergic-monoaminergic interactions contribute to EEG slowing and dementia.
Behav Brain Res. 2000 Nov;115(2):235-49. Review.
PMID: 11000423 [PubMed - indexed for MEDLINE]


11: Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, WinbladB, Wahlund LO.
Quantitative electroencephalography in mild cognitive impairment: longitudinal
changes and possible prediction of Alzheimer's disease.
Neurobiol Aging. 2000 Jul-Aug;21(4):533-40.
PMID: 10924766 [PubMed - indexed for MEDLINE]


12: Knott V, Mohr E, Mahoney C, Ilivitsky V.Pharmaco-EEG test dose response predicts cholinesterase inhibitor treatment
outcome in Alzheimer's disease.
Methods Find Exp Clin Pharmacol. 2000 Mar;22(2):115-22.
PMID: 10849895 [PubMed - indexed for MEDLINE]


13: Anghinah R, Kanda PA, Jorge MS, Lima EE, Pascuzzi L, Melo AC.[Alpha band coherence analysis of EEG in healthy adult's and Alzheimer's type
dementia patients]
Arq Neuropsiquiatr. 2000 Jun;58(2A):272-5. Portuguese.
PMID: 10849626 [PubMed - indexed for MEDLINE]


14: Knott V, Engeland C, Mohr E, Mahoney C, Ilivitsky V.Acute nicotine administration in Alzheimer's disease: an exploratory EEG study.
Neuropsychobiology. 2000;41(4):210-20.
PMID: 10828731 [PubMed - indexed for MEDLINE]


15: Claus JJ, Ongerboer De Visser BW, Bour LJ, Walstra GJ, Hijdra A, Verbeeten BJr, Van Royen EA, Kwa VI, van Gool WA.
Determinants of quantitative spectral electroencephalography in early
Alzheimer's disease: cognitive function, regional cerebral blood flow, and
computed tomography.
Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):81-9.
PMID: 10705165 [PubMed - indexed for MEDLINE]


16: Ihl R, Brinkmeyer J, Janner M, Kerdar MS.A comparison of ADAS and EEG in the discrimination of patients with dementia of
the Alzheimer type from healthy controls.
Neuropsychobiology. 2000 Jan;41(2):102-7.
PMID: 10644931 [PubMed - indexed for MEDLINE]


17: Lehtovirta M, Partanen J, Kononen M, Hiltunen J, Helisalmi S, Hartikainen P,Riekkinen P Sr, Soininen H.

A longitudinal quantitative EEG study of Alzheimer's disease: relation to
apolipoprotein E polymorphism.
Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):29-35.
PMID: 10629359 [PubMed - indexed for MEDLINE]





1: Meguro K, LeMestric C, Landeau B, Desgranges B, Eustache F, Baron JC.Relations between hypometabolism in the posterior association neocortex and
hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.
J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):315-21.
PMID: 11511703 [PubMed - indexed for MEDLINE]


2: Versijpt J, Decoo D, Van Laere KJ, Achten E, Audenaert K, D'Asseler Y,Slegers G, Dierckx RA, Korf J.
57Co SPECT, 99mTc-ECD SPECT, MRI and neuropsychological testing in senile
dementia of the Alzheimer type.
Nucl Med Commun. 2001 Jun;22(6):713-9.
PMID: 11403184 [PubMed - indexed for MEDLINE]


3: Ishii K, Willoch F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, Kuhl DE,Schwaiger M.
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of
anatomic standardization for atrophied brains.
J Nucl Med. 2001 Apr;42(4):548-57.
PMID: 11337540 [PubMed - indexed for MEDLINE]


4: Crum WR, Scahill RI, Fox NC.Automated hippocampal segmentation by regional fluid registration of serial MRI:
validation and application in Alzheimer's disease.
Neuroimage. 2001 May;13(5):847-55.
PMID: 11304081 [PubMed - indexed for MEDLINE]


5: Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Hu XS, Takeda A, Itoh M,Sasaki H.
[18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
Prog Neuropsychopharmacol Biol Psychiatry. 2001 Feb;25(2):447-56.
PMID: 11294488 [PubMed - indexed for MEDLINE]


6: Eustache F, Desgranges B, Giffard B, de la Sayette V, Baron JC.Entorhinal cortex disruption causes memory deficit in early Alzheimer's disease
as shown by PET.
Neuroreport. 2001 Mar 26;12(4):683-5.
PMID: 11277563 [PubMed - indexed for MEDLINE]


7: Kawano M, Ichimiya A, Ogomori K, Kuwabara Y, Sasaki M, Yoshida T, Tashiro N.Relationship between both IQ and Mini-Mental State Examination and the regional
cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: a PET
study.
Dement Geriatr Cogn Disord. 2001 Mar-Apr;12(2):171-6.
PMID: 11173892 [PubMed - indexed for MEDLINE]


8: Zubieta JK, Koeppe RA, Frey KA, Kilbourn MR, Mangner TJ, Foster NL, Kuhl DE.Assessment of muscarinic receptor concentrations in aging and Alzheimer disease
with [11C]NMPB and PET.
Synapse. 2001 Mar 15;39(4):275-87.
PMID: 11169777 [PubMed - indexed for MEDLINE]

9: Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT.MRI volumetric correlates of white matter lesions in dementia with Lewy bodies
and Alzheimer's disease.
Int J Geriatr Psychiatry. 2000 Oct;15(10):911-6.
PMID: 11044873 [PubMed - indexed for MEDLINE]


10: Doody RS, Azher SN, Haykal HA, Dunn JK, Liao T, Schneider L.Does APO epsilon4 correlate with MRI changes in Alzheimer's disease?
J Neurol Neurosurg Psychiatry. 2000 Nov;69(5):668-71.
PMID: 11032626 [PubMed - indexed for MEDLINE]


11: Dierks T, Jelic V, Pascual-Marqui RD, Wahlund L, Julin P, Linden DE, MaurerK, Winblad B, Nordberg A.
Spatial pattern of cerebral glucose metabolism (PET) correlates with
localization of intracerebral EEG-generators in Alzheimer's disease.
Clin Neurophysiol. 2000 Oct;111(10):1817-24.
PMID: 11018498 [PubMed - indexed for MEDLINE]


12: Small SA, Nava AS, Perera GM, Delapaz R, Stern Y.Evaluating the function of hippocampal subregions with high-resolution MRI in
Alzheimer's disease and aging.
Microsc Res Tech. 2000 Oct 1;51(1):101-8.
PMID: 11002358 [PubMed - indexed for MEDLINE]


13: Bartzokis G, Tishler TA.MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's
and Huntingon's disease.
Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.
PMID: 10875443 [PubMed - indexed for MEDLINE]


14: Laakso MP, Frisoni GB, Kononen M, Mikkonen M, Beltramello A, Geroldi C,Bianchetti A, Trabucchi M, Soininen H, Aronen HJ.
Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's
disease: a morphometric MRI study.
Biol Psychiatry. 2000 Jun 15;47(12):1056-63.
PMID: 10862805 [PubMed - indexed for MEDLINE]


15: Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, Sato M, Satoh Y,Watahiki Y, Hirata Y, Yokoyama E, Hatazawa J.
Can PET data differentiate Alzheimer's disease from vascular dementia?
Ann N Y Acad Sci. 2000 Apr;903:252-61.
PMID: 10818514 [PubMed - indexed for MEDLINE]


16: Pietrini P, Alexander GE, Furey ML, Dani A, Mentis MJ, Horwitz B, GuazzelliM, Shapiro MB, Rapoport SI.
Cerebral metabolic response to passive audiovisual stimulation in patients with
Alzheimer's disease and healthy volunteers assessed by PET.
J Nucl Med. 2000 Apr;41(4):575-83.
PMID: 10768555 [PubMed - indexed for MEDLINE]

17: Denihan A, Wilson G, Cunningham C, Coakley D, Lawlor BA.CT measurement of medial temporal lobe atrophy in Alzheimer's disease, vascular
dementia, depression and paraphrenia.
Int J Geriatr Psychiatry. 2000 Apr;15(4):306-12.
PMID: 10767729 [PubMed - indexed for MEDLINE]


18: Ohyama M, Senda M, Mishina M, Kitamura S, Tanizaki N, Ishii K, Katayama Y.Semi-automatic ROI placement system for analysis of brain PET images based on
elastic model: application to diagnosis of Alzheimer's disease.
Keio J Med. 2000 Feb;49 Suppl 1:A105-6.
PMID: 10750353 [PubMed - indexed for MEDLINE]


19: Kobari M, Meyer JS, Ichijo M, Kawamura J.Distinguishing patients with senile dementia of Alzheimer type and normal
elderly subjects utilizing xenon CT-CBF and multivariate analysis.
Keio J Med. 2000 Feb;49 Suppl 1:A101-4.
PMID: 10750352 [PubMed - indexed for MEDLINE]


20: Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, CovelliEM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B.
Measurement of global brain atrophy in Alzheimer's disease with unsupervised
segmentation of spin-echo MRI studies.
J Magn Reson Imaging. 2000 Mar;11(3):260-6.
PMID: 10739557 [PubMed - indexed for MEDLINE]


21: Laakso MP, Lehtovirta M, Partanen K, Riekkinen PJ, Soininen H.Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study.
Biol Psychiatry. 2000 Mar 15;47(6):557-61.
PMID: 10715362 [PubMed - indexed for MEDLINE]


22: O'Brien JT, Metcalfe S, Swann A, Hobson J, Jobst K, Ballard C, McKeith I,Gholkar A.
Medial temporal lobe width on CT scanning in Alzheimer's disease: comparison
with vascular dementia, depression and dementia with Lewy bodies.
Dement Geriatr Cogn Disord. 2000 Mar-Apr;11(2):114-8.
PMID: 10705169 [PubMed - indexed for MEDLINE]


23: Laakso MP, Hallikainen M, Hanninen T, Partanen K, Soininen H.Diagnosis of Alzheimer's disease: MRI of the hippocampus vs delayed recall.
Neuropsychologia. 2000;38(5):579-84.
PMID: 10689035 [PubMed - indexed for MEDLINE]


24: Mizuno K, Wakai M, Takeda A, Sobue G.Medial temporal atrophy and memory impairment in early stage of Alzheimer's
disease: an MRI volumetric and memory assessment study.
J Neurol Sci. 2000 Feb 1;173(1):18-24.
PMID: 10675575 [PubMed - indexed for MEDLINE]


25: Geroldi C, Laakso MP, DeCarli C, Beltramello A, Bianchetti A, Soininen H,

Trabucchi M, Frisoni GB.
Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a
volumetric MRI study.
J Neurol Neurosurg Psychiatry. 2000 Jan;68(1):93-6.
PMID: 10601411 [PubMed - indexed for MEDLINE]

1: Kim DK, Seo MY, Lim SW, Kim S, Kim JW, Carroll BJ, Kwon DY, Kwon T, Kang SS.Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease.
Neuropsychopharmacology. 2001 Jul;25(1):84-90.
PMID: 11377921 [PubMed - indexed for MEDLINE]


2: Kennard ML, Feldman H, Yamada T, Jefferies WA.Serum levels of the iron binding protein p97 are elevated in Alzheimer's
disease.
Nat Med. 1996 Nov;2(11):1230-5.
PMID: 8898750 [PubMed - indexed for MEDLINE]

1: Bacon Moore AS, Paulsen JS, Murphy C.A test of odor fluency in patients with Alzheimer's and Huntington's disease.
J Clin Exp Neuropsychol. 1999 Jun;21(3):341-51.
PMID: 10474173 [PubMed - indexed for MEDLINE]


2: Larsson M, Semb H, Winblad B, Amberla K, Wahlund LO, Backman L.Odor identification in normal aging and early Alzheimer's disease: effects of
retrieval support.
Neuropsychology. 1999 Jan;13(1):47-53.
PMID: 10067775 [PubMed - indexed for MEDLINE]


3: Nordin S, Murphy C.Odor memory in normal aging and Alzheimer's disease.
Ann N Y Acad Sci. 1998 Nov 30;855:686-93. Review.
PMID: 9929672 [PubMed - indexed for MEDLINE]


4: Morgan CD, Nordin S, Murphy C.Odor identification as an early marker for Alzheimer's disease: impact of
lexical functioning and detection sensitivity.
J Clin Exp Neuropsychol. 1995 Oct;17(5):793-803.
PMID: 8557819 [PubMed - indexed for MEDLINE]



1: Nakano S, Asada T, Matsuda H, Uno M, Takasaki M.Donepezil hydrochloride preserves regional cerebral blood flow in patients with
Alzheimer's disease.
J Nucl Med. 2001 Oct;42(10):1441-5.
PMID: 11585854 [PubMed - indexed for MEDLINE]


2: Wilkinson D, Murray J.Galantamine: a randomized, double-blind, dose comparison in patients with
Alzheimer's disease.
Int J Geriatr Psychiatry. 2001 Sep;16(9):852-7.
PMID: 11571763 [PubMed - indexed for MEDLINE]


3: Getsios D, Caro JJ, Caro G, Ishak K.Assessment of health economics in Alzheimer's disease (AHEAD): galantamine
treatment in Canada.
Neurology. 2001 Sep 25;57(6):972-8.
PMID: 11571319 [PubMed - indexed for MEDLINE]


4: Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E.A 24-week, randomized, double-blind study of donepezil in moderate to severe
Alzheimer's disease.
Neurology. 2001 Aug 28;57(4):613-20.
PMID: 11524468 [PubMed - indexed for MEDLINE]


5: Cummings JL, Nadel A, Masterman D, Cyrus PA.Efficacy of metrifonate in improving the psychiatric and behavioral disturbances
of patients with Alzheimer's disease.
J Geriatr Psychiatry Neurol. 2001 Summer;14(2):101-8.
PMID: 11419566 [PubMed - indexed for MEDLINE]


6: Ferris SH.Switching previous therapies for Alzheimer's disease to galantamine.
Clin Ther. 2001;23 Suppl A:A3-7.
PMID: 11396869 [PubMed - indexed for MEDLINE]


7: Farlow MR.Pharmacokinetic profiles of current therapies for Alzheimer's disease:
implications for switching to galantamine.
Clin Ther. 2001;23 Suppl A:A13-24.
PMID: 11396867 [PubMed - indexed for MEDLINE]


8: Doody RS, Dunn JK, Clark CM, Farlow M, Foster NL, Liao T, Gonzales N, Lai E,Massman P.
Chronic donepezil treatment is associated with slowed cognitive decline in
Alzheimer's disease.
Dement Geriatr Cogn Disord. 2001 Jul-Aug;12(4):295-300.
PMID: 11351141 [PubMed - indexed for MEDLINE]


9: Adler G, Brassen S.

Short-term rivastigmine treatment reduces EEG slow-wave power in Alzheimer
patients.
Neuropsychobiology. 2001;43(4):273-6.
PMID: 11340368 [PubMed - indexed for MEDLINE]


10: Lamb HM, Goa KL.Rivastigmine. A pharmacoeconomic review of its use in Alzheimer's disease.
Pharmacoeconomics. 2001;19(3):303-18. Review.
PMID: 11303418 [PubMed - indexed for MEDLINE]


11: Thomas A, Iacono D, Bonanni L, D'Andreamatteo G, Onofrj M.Donepezil, rivastigmine, and vitamin E in Alzheimer disease: a combined P300
event-related potentials/neuropsychologic evaluation over 6 months.
Clin Neuropharmacol. 2001 Jan-Feb;24(1):31-42.
PMID: 11290880 [PubMed - indexed for MEDLINE]


12: Bryant J, Clegg A, Nicholson T, McIntyre L, De Broe S, Gerard K, Waugh N.Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for
Alzheimer's disease: a rapid and systematic review.
Health Technol Assess. 2001;5(1):1-137. Review.
PMID: 11262420 [PubMed - indexed for MEDLINE]


13: Doody RS, Geldmacher DS, Gordon B, Perdomo CA, Pratt RD.Open-label, multicenter, phase 3 extension study of the safety and efficacy of
donepezil in patients with Alzheimer disease.
Arch Neurol. 2001 Mar;58(3):427-33.
PMID: 11255446 [PubMed - indexed for MEDLINE]


14: Farlow MR, Hake A, Messina J, Hartman R, Veach J, Anand R.Response of patients with Alzheimer disease to rivastigmine treatment is
predicted by the rate of disease progression.
Arch Neurol. 2001 Mar;58(3):417-22.
PMID: 11255445 [PubMed - indexed for MEDLINE]


15: Mega MS, Cummings JL, O'Connor SM, Dinov ID, Reback E, Felix J, MastermanDL, Phelps ME, Small GW, Toga AW.
Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease.
Neuropsychiatry Neuropsychol Behav Neurol. 2001 Jan;14(1):63-8.
PMID: 11234910 [PubMed - indexed for MEDLINE]


16: Coyle J, Kershaw P.Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic
receptors: effects on the course of Alzheimer's disease.
Biol Psychiatry. 2001 Feb 1;49(3):289-99. Review.
PMID: 11230880 [PubMed - indexed for MEDLINE]


17: Maelicke A, Samochocki M, Jostock R, Fehrenbacher A, Ludwig J, AlbuquerqueEX, Zerlin M.
Allosteric sensitization of nicotinic receptors by galantamine, a new treatment
strategy for Alzheimer's disease.

Biol Psychiatry. 2001 Feb 1;49(3):279-88. Review. PMID: 11230879 [PubMed - indexed for MEDLINE]

18: Baladi JF, Bailey PA, Black S, Bouchard RW, Farcnik KD, Gauthier S, KerteszA, Mohr E, Robillard A.
Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate
outcome measures and cost implications.
Clin Ther. 2000 Dec;22(12):1549-61.
PMID: 11192146 [PubMed - indexed for MEDLINE]


19: Aerssens J, Raeymaekers P, Lilienfeld S, Geerts H, Konings F, Parys W.APOE genotype: no influence on galantamine treatment efficacy nor on rate of
decline in Alzheimer's disease.
Dement Geriatr Cogn Disord. 2001 Mar-Apr;12(2):69-77.
PMID: 11173877 [PubMed - indexed for MEDLINE]


20: Gelinas I, Gauthier S, Cyrus PA.Metrifonate enhances the ability of Alzheimer's disease patients to initiate,
organize, and execute instrumental and basic activities of daily living.
J Geriatr Psychiatry Neurol. 2000 Spring;13(1):9-16.
PMID: 10753002 [PubMed - indexed for MEDLINE]


21: Scott LJ, Goa KL.Galantamine: a review of its use in Alzheimer's disease.
Drugs. 2000 Nov;60(5):1095-122. Review.
PMID: 11129124 [PubMed - indexed for MEDLINE]


22: Almkvist O, Jelic V, Amberla K, Hellstrom-Lindahl E, Meurling L, Nordberg A.Responder characteristics to a single oral dose of cholinesterase inhibitor: a
double-blind placebo-controlled study with tacrine in Alzheimer patients.
Dement Geriatr Cogn Disord. 2001 Jan-Feb;12(1):22-32.
PMID: 11125238 [PubMed - indexed for MEDLINE]


23: Wilcock GK, Lilienfeld S, Gaens E.Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's
disease: multicentre randomised controlled trial. Galantamine International-1
Study Group.
BMJ. 2000 Dec 9;321(7274):1445-9.
PMID: 11110737 [PubMed - indexed for MEDLINE]


24: Camps P, El Achab R, Morral J, Munoz-Torrero D, Badia A, Banos JE, Vivas NM,Barril X, Orozco M, Luque FJ.
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding
acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's
disease.
J Med Chem. 2000 Nov 30;43(24):4657-66.
PMID: 11101357 [PubMed - indexed for MEDLINE]


25: Farlow M, Anand R, Messina J Jr, Hartman R, Veach J.A 52-week study of the efficacy of rivastigmine in patients with mild to

moderately severe Alzheimer's disease.
Eur Neurol. 2000;44(4):236-41.
PMID: 11096224 [PubMed - indexed for MEDLINE]


26: Lopez-Pousa S, Vilalta-Franch J, Garre-Olmo J, Turon-Estrada A,Hernandez-Ferrandiz M, Cruz-Reina ML.
[Effectiveness of donepezil at six months in the treatment of cognition
deterioration in patients with Alzheimer-type dementia]
Rev Neurol. 2000 Oct 16-31;31(8):724-8. Spanish.
PMID: 11082878 [PubMed - indexed for MEDLINE]


27: Fillit HM, Gutterman EM, Brooks RL.Impact of donepezil on caregiving burden for patients with Alzheimer's disease.
Int Psychogeriatr. 2000 Sep;12(3):389-401.
PMID: 11081959 [PubMed - indexed for MEDLINE]


28: Cameron I, Curran S, Newton P, Petty D, Wattis J.Use of donepezil for the treatment of mild-moderate Alzheimer's disease: an
audit of the assessment and treatment of patients in routine clinical practice.
Int J Geriatr Psychiatry. 2000 Oct;15(10):887-91.
PMID: 11044869 [PubMed - indexed for MEDLINE]


29: Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, Nishimura T.Clinical efficacy and safety of donepezil on cognitive and global function in
patients with Alzheimer's disease. A 24-week, multicenter, double-blind,
placebo-controlled study in Japan. E2020 Study Group.
Dement Geriatr Cogn Disord. 2000 Nov-Dec;11(6):299-313.
PMID: 11044775 [PubMed - indexed for MEDLINE]


30: Birks JS, Melzer D, Beppu H.Donepezil for mild and moderate Alzheimer's disease.
Cochrane Database Syst Rev. 2000;(4):CD001190. Review.
PMID: 11034704 [PubMed - indexed for MEDLINE]


31: Birks J, Grimley Evans J, Iakovidou V, Tsolaki M.Rivastigmine for Alzheimer's disease.
Cochrane Database Syst Rev. 2000;(4):CD001191. Review.
PMID: 11034705 [PubMed - indexed for MEDLINE]


32: Kuhl DE, Minoshima S, Frey KA, Foster NL, Kilbourn MR, Koeppe RA.Limited donepezil inhibition of acetylcholinesterase measured with positron
emission tomography in living Alzheimer cerebral cortex.
Ann Neurol. 2000 Sep;48(3):391-5.
PMID: 10976649 [PubMed - indexed for MEDLINE]


33: Lilienfeld S, Parys W.Galantamine: additional benefits to patients with Alzheimer's disease.
Dement Geriatr Cogn Disord. 2000 Sep;11 Suppl 1:19-27. Review.
PMID: 10971048 [PubMed - indexed for MEDLINE]

34: Matthews HP, Korbey J, Wilkinson DG, Rowden J.Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory
Clinic.
Int J Geriatr Psychiatry. 2000 Aug;15(8):713-20.
PMID: 10960883 [PubMed - indexed for MEDLINE]


35: Hauber AB, Gnanasakthy A, Snyder EH, Bala MV, Richter A, Mauskopf JA.Potential savings in the cost of caring for Alzheimer's disease. Treatment with
rivastigmine.
Pharmacoeconomics. 2000 Apr;17(4):351-60. Review.
PMID: 10947490 [PubMed - indexed for MEDLINE]


36: Kamal MA, Alhomida AS, Al-Rajhi AA, Al-Jafari AA.Thermodynamic analysis of human retinal acetylcholinesterase inhibition using an
anti-Alzheimer's drug, tacrine, through the development of a dual substrate and
temperature model.
Proc Natl Sci Counc Repub China B. 2000 Jul;24(3):108-15.
PMID: 10943943 [PubMed - indexed for MEDLINE]


37: Weiner MF, Martin-Cook K, Foster BM, Saine K, Fontaine CS, Svetlik DA.Effects of donepezil on emotional/behavioral symptoms in Alzheimer's disease
patients.
J Clin Psychiatry. 2000 Jul;61(7):487-92.
PMID: 10937606 [PubMed - indexed for MEDLINE]


38: Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S.Tacrine for Alzheimer's disease.
Cochrane Database Syst Rev. 2000;(3):CD000202. Review.
PMID: 10908463 [PubMed - indexed for MEDLINE]


39: Rigaud AS, Traykov L, Caputo L, Guelfi MC, Latour F, Couderc R, Moulin F, deRotrou J, Forette F, Boller F.
The apolipoprotein E epsilon4 allele and the response to tacrine therapy in
Alzheimer's disease.
Eur J Neurol. 2000 May;7(3):255-8.
PMID: 10886308 [PubMed - indexed for MEDLINE]


40: Ogura H, Kosasa T, Araki S, Yamanishi Y.[Pharmacological properties of donepezil hydrochloride (Aricept), a drug for
Alzheimer's disease]
Nippon Yakurigaku Zasshi. 2000 Jan;115(1):45-51. Review. Japanese.
PMID: 10876815 [PubMed - indexed for MEDLINE]


41: Farlow MR, Cyrus PA.Metrifonate therapy in Alzheimer's disease: a pooled analysis of four
randomized, double-blind, placebo-controlled trials.
Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):202-11.
PMID: 10867446 [PubMed - indexed for MEDLINE]

42: Rivastigmine for Alzheimer's disease.Drug Ther Bull. 2000 Feb;38(2):15-6. Review.
PMID: 10829350 [PubMed - indexed for MEDLINE]


43: Hauber AB, Gnanasakthy A, Mauskopf JA.Savings in the cost of caring for patients with Alzheimer's disease in Canada:
an analysis of treatment with rivastigmine.
Clin Ther. 2000 Apr;22(4):439-51.
PMID: 10823365 [PubMed - indexed for MEDLINE]


44: Cummings JL, Donohue JA, Brooks RL.The relationship between donepezil and behavioral disturbances in patients with
Alzheimer's disease.
Am J Geriatr Psychiatry. 2000 Spring;8(2):134-40.
PMID: 10804074 [PubMed - indexed for MEDLINE]


45: Dooley M, Lamb HM.Donepezil: a review of its use in Alzheimer's disease.
Drugs Aging. 2000 Mar;16(3):199-226. Review.
PMID: 10803860 [PubMed - indexed for MEDLINE]


46: Alagiakrishnan K, Wong W, Blanchette PL.Use of donepezil in elderly patients with Alzheimer's disease--a Hawaii based
study.
Hawaii Med J. 2000 Feb;59(2):57-9.
PMID: 10800254 [PubMed - indexed for MEDLINE]


47: Birks J, Iakovidou V, Tsolaki M.Rivastigmine for Alzheimer's disease.
Cochrane Database Syst Rev. 2000;(2):CD001191. Review.
PMID: 10796621 [PubMed - indexed for MEDLINE]


48: Birks J S, Melzer D.Donepezil for mild and moderate Alzheimer's disease.
Cochrane Database Syst Rev. 2000;(2):CD001190. Review.
PMID: 10796620 [PubMed - indexed for MEDLINE]


49: Qizilbash N, Birks J, Lopez-Arrieta J, Lewington S, Szeto S.Tacrine for Alzheimer's disease.
Cochrane Database Syst Rev. 2000;(2):CD000202. Review.
PMID: 10796507 [PubMed - indexed for MEDLINE]


50: Rogers SL, Doody RS, Pratt RD, Ieni JR.Long-term efficacy and safety of donepezil in the treatment of Alzheimer's
disease: final analysis of a US multicentre open-label study.
Eur Neuropsychopharmacol. 2000 May;10(3):195-203.
PMID: 10793322 [PubMed - indexed for MEDLINE]


51: Unni L, Vicari S, Moriearty P, Schaefer F, Becker R.

The recovery of cerebrospinal fluid acetylcholinesterase activity in Alzheimer's
disease patients after treatment with metrifonate.
Methods Find Exp Clin Pharmacol. 2000 Jan-Feb;22(1):57-61.
PMID: 10791297 [PubMed - indexed for MEDLINE]


52: Shikiar R, Shakespeare A, Sagnier PP, Wilkinson D, McKeith I, Dartigues JF,Dubois B.
The impact of metrifonate therapy on caregivers of patients with Alzheimer's
disease: results from the MALT clinical trial. Metrifonate in Alzheimer's
Disease Trial.
J Am Geriatr Soc. 2000 Mar;48(3):268-74.
PMID: 10733052 [PubMed - indexed for MEDLINE]


53: Staff RT, Gemmell HG, Shanks MF, Murray AD, Venneri A.Changes in the rCBF images of patients with Alzheimer's disease receiving
Donepezil therapy.
Nucl Med Commun. 2000 Jan;21(1):37-41.
PMID: 10717900 [PubMed - indexed for MEDLINE]


54: Blass JP, Cyrus PA, Bieber F, Gulanski B.Randomized, double-blind, placebo-controlled, multicenter study to evaluate the
safety and tolerability of metrifonate in patients with probable Alzheimer
disease. The Metrifonate Study Group.
Alzheimer Dis Assoc Disord. 2000 Jan-Mar;14(1):39-45.
PMID: 10718203 [PubMed - indexed for MEDLINE]


55: Jann MW.Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of
Alzheimer's disease.
Pharmacotherapy. 2000 Jan;20(1):1-12. Review.
PMID: 10641971 [PubMed - indexed for MEDLINE]


56: Evans M, Ellis A, Watson D, Chowdhury T.Sustained cognitive improvement following treatment of Alzheimer's disease with
donepezil.
Int J Geriatr Psychiatry. 2000 Jan;15(1):50-3.
PMID: 10637404 [PubMed - indexed for MEDLINE]

1: McKenna DJ, Jones K, Hughes K.Efficacy, safety, and use of ginkgo biloba in clinical and preclinical
applications.
Altern Ther Health Med. 2001 Sep-Oct;7(5):70-86, 88-90. Review.
PMID: 11565403 [PubMed - indexed for MEDLINE]


2: DeFeudis FV, Drieu K.Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical
applications.
Curr Drug Targets. 2000 Jul;1(1):25-58. Review.
PMID: 11475535 [PubMed - indexed for MEDLINE]


3: Stough C, Clarke J, Lloyd J, Nathan PJ.Neuropsychological changes after 30-day Ginkgo biloba administration in healthy
participants.
Int J Neuropsychopharmacol. 2001 Jun;4(2):131-4.
PMID: 11466162 [PubMed - indexed for MEDLINE]


4: Zoller B, Hock C, Kull HU.[Rational therapy of Alzheimer dementia based on current clinical studies]
Schweiz Rundsch Med Prax. 2001 May 10;90(19):827-34. German.
PMID: 11407240 [PubMed - indexed for MEDLINE]


5: Wettstein A.Cholinesterase inhibitors and Gingko extracts--are they comparable in the
treatment of dementia? Comparison of published placebo-controlled efficacy
studies of at least six months' duration.
Phytomedicine. 2000 Jan;6(6):393-401.
PMID: 10755847 [PubMed - indexed for MEDLINE]


6: van Dongen MC, van Rossum E, Kessels AG, Sielhorst HJ, Knipschild PG.The efficacy of ginkgo for elderly people with dementia and age-associated
memory impairment: new results of a randomized clinical trial.
J Am Geriatr Soc. 2000 Oct;48(10):1183-94.
PMID: 11037003 [PubMed - indexed for MEDLINE]


7: Le Bars PL, Kieser M, Itil KZ.A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo
biloba extract EGb 761 in dementia.
Dement Geriatr Cogn Disord. 2000 Jul-Aug;11(4):230-7.
PMID: 10867450 [PubMed - indexed for MEDLINE]


8: Forstl H.Clinical issues in current drug therapy for dementia.
Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S103-8.
PMID: 10850737 [PubMed - indexed for MEDLINE]


9: Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA,Schoenberger NE.

Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil. 2000 May;81(5):668-78. Review. PMID: 10807109 [PubMed - indexed for MEDLINE]

10: Christen Y.Oxidative stress and Alzheimer disease.
Am J Clin Nutr. 2000 Feb;71(2):621S-629S. Review.
PMID: 10681270 [PubMed - indexed for MEDLINE]

1: Cooper JD, Salehi A, Delcroix JD, Howe CL, Belichenko PV, Chua-Couzens J,Kilbridge JF, Carlson EJ, Epstein CJ, Mobley WC.
Failed retrograde transport of NGF in a mouse model of Down's syndrome: reversal
of cholinergic neurodegenerative phenotypes following NGF infusion.
Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10439-44.
PMID: 11504920 [PubMed - indexed for MEDLINE]


2: Allen SJ, Robertson AG, Tyler SJ, Wilcock GK, Dawbarn D.Recombinant human nerve growth factor for clinical trials: protein expression,
purification, stability and characterisation of binding to infusion pumps.
J Biochem Biophys Methods. 2001 Feb 26;47(3):239-55.
PMID: 11245895 [PubMed - indexed for MEDLINE]


3: Rattray M.Is there nicotinic modulation of nerve growth factor? Implications for
cholinergic therapies in Alzheimer's disease.
Biol Psychiatry. 2001 Feb 1;49(3):185-93. Review.
PMID: 11230869 [PubMed - indexed for MEDLINE]


4: Jonnala RR, Buccafusco JJ.Inhibition of nerve growth factor signaling by peroxynitrite.
J Neurosci Res. 2001 Jan 1;63(1):27-34.
PMID: 11169611 [PubMed - indexed for MEDLINE]


5: Villa AE, Tetko IV, Dutoit P, Vantini G.Non-linear cortico-cortical interactions modulated by cholinergic afferences
from the rat basal forebrain.
Biosystems. 2000 Oct-Dec;58(1-3):219-28.
PMID: 11164650 [PubMed - indexed for MEDLINE]


6: Deigner HP, Haberkorn U, Kinscherf R.Apoptosis modulators in the therapy of neurodegenerative diseases.
Expert Opin Investig Drugs. 2000 Apr;9(4):747-64. Review.
PMID: 11060707 [PubMed - indexed for MEDLINE]


7: Granholm AC.Oestrogen and nerve growth factor - neuroprotection and repair in Alzheimer's
disease.
Expert Opin Investig Drugs. 2000 Apr;9(4):685-94. Review.
PMID: 11060702 [PubMed - indexed for MEDLINE]


8: Sienkiewicz-Jarosz H, Kostowski W.[Perspectives of therapy of Alzheimer's disease]
Psychiatr Pol. 2000 Jul-Aug;34(4):623-40. Review. Polish.
PMID: 11059261 [PubMed - indexed for MEDLINE]


9: Murer MG, Yan Q, Raisman-Vozari R.Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's
disease and Parkinson's disease.

Prog Neurobiol. 2001 Jan;63(1):71-124. Review. PMID: 11040419 [PubMed - indexed for MEDLINE]

10: Windisch M.Approach towards an integrative drug treatment of Alzheimer's disease.
J Neural Transm Suppl. 2000;59:301-13. Review.
PMID: 10961442 [PubMed - indexed for MEDLINE]


11: Hock CH, Heese K, Olivieri G, Hulette CH, Rosenberg C, Nitsch RM, Otten U.Alterations in neurotrophins and neurotrophin receptors in Alzheimer's disease.
J Neural Transm Suppl. 2000;59:171-4.
PMID: 10961429 [PubMed - indexed for MEDLINE]


12: Hock C, Heese K, Hulette C, Rosenberg C, Otten U.Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels
of brain-derived neurotrophic factor and increased levels of nerve growth factor
in hippocampus and cortical areas.
Arch Neurol. 2000 Jun;57(6):846-51.
PMID: 10867782 [PubMed - indexed for MEDLINE]


13: Nabeshima T, Yamada K.Neurotrophic factor strategies for the treatment of Alzheimer disease.
Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S39-46. Review.
PMID: 10850729 [PubMed - indexed for MEDLINE]


14: Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A.Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic
mice.
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6826-31.
PMID: 10841577 [PubMed - indexed for MEDLINE]


15: Hock C, Heese K, Muller-Spahn F, Huber P, Riesen W, Nitsch RM, Otten U.Increased CSF levels of nerve growth factor in patients with Alzheimer's
disease.
Neurology. 2000 May 23;54(10):2009-11.
PMID: 10822447 [PubMed - indexed for MEDLINE]

1: Scherder EJ, Van Someren EJ, Bouma A, v d Berg M.Effects of transcutaneous electrical nerve stimulation (TENS) on cognition and
behaviour in aging.
Behav Brain Res. 2000 Jun 15;111(1-2):223-5.
PMID: 10840147 [PubMed - indexed for MEDLINE]


  1. 2: Golomb J, Wisoff J, Miller DC, Boksay I, Kluger A, Weiner H, Salton J, Graves

  2. W.
    Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and
    shunt response.
    J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):778-81.
    PMID: 10811706 [PubMed - indexed for MEDLINE]




3: Iddon JL, Pickard JD, Cross JJ, Griffiths PD, Czosnyka M, Sahakian BJ.Specific patterns of cognitive impairment in patients with idiopathic normal
pressure hydrocephalus and Alzheimer's disease: a pilot study.
J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):723-32.
PMID: 10567486 [PubMed - indexed for MEDLINE]


4: Scherder EJ, Van Someren EJ, Swaab DF.Transcutaneous electrical nerve stimulation (TENS) improves the rest-activity
rhythm in midstage Alzheimer's disease.
Behav Brain Res. 1999 May;101(1):105-7.
PMID: 10342404 [PubMed - indexed for MEDLINE]


5: Scherder EJ, Bouma A.Effects of transcutaneous electrical nerve stimulation on memory and behavior in
Alzheimer's disease may be stage-dependent.
Biol Psychiatry. 1999 Mar 15;45(6):743-9.
PMID: 10188004 [PubMed - indexed for MEDLINE]


6: Van Someren EJ, Scherder EJ, Swaab DF.Transcutaneous electrical nerve stimulation (TENS) improves circadian rhythm
disturbances in Alzheimer disease.
Alzheimer Dis Assoc Disord. 1998 Jun;12(2):114-8.
PMID: 9651141 [PubMed - indexed for MEDLINE]


7: Scherder EJ, Bouma A, Steen LM.Effects of "isolated" transcutaneous electrical nerve stimulation on memory and
affective behavior in patients with probable Alzheimer's disease.
Biol Psychiatry. 1998 Mar 15;43(6):417-24.
PMID: 9532346 [PubMed - indexed for MEDLINE]

1   2   3   4   5   6   7   8   9

similar:

¿Qué es la enfermedad de Alzheimer? icon¿QUÉ tal que ya existiera la cura para la enfermedad de alzheimer y nadie lo supiera?

¿Qué es la enfermedad de Alzheimer? iconEnfermedad de Alzheimer

¿Qué es la enfermedad de Alzheimer? iconEnfermedad de Alzheimer De Wikipedia, la enciclopedia libre

¿Qué es la enfermedad de Alzheimer? iconConclusiones "Los costes de la enfermedad de Alzheimer"

¿Qué es la enfermedad de Alzheimer? iconSujeciones químicas en personas con enfermedad de Alzheimer

¿Qué es la enfermedad de Alzheimer? iconEfectos del ejercicio multimodal en pacientes con la enfermedad de...

¿Qué es la enfermedad de Alzheimer? icon¿Qué es una enfermedad transmitida por alimentos?

¿Qué es la enfermedad de Alzheimer? icon1. Explica en qué consiste la progeria e indica los problemas de...

¿Qué es la enfermedad de Alzheimer? iconAula 1 Química. Campus Libertad. Av Libertad 5470. Corrientes
«sin carga», entendiéndose por carga un impuesto, ley o enfermedad. Se dice que aquellos individuos que no sucumben ante la enfermedad...

¿Qué es la enfermedad de Alzheimer? icon¿Qué provoca el enfrentamiento de Sempronio y Celestina?(pp. 120-121)...
«pecado» para Celestina? ¿Qué remedio infalible le sugiere a Areúsa para curar su mal? (p. 154) ¿Qué última lección le da Celestina...


Medicina





Todos los derechos reservados. Copyright © 2015
contactos
med.se-todo.com